Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05103345
Title	Study of SGN1 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumor
Recruitment	Recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Guangzhou Sinogen Pharmaceutical Co., Ltd
Indications	sarcoma non-Hodgkin lymphoma head and neck cancer lung small cell carcinoma melanoma Hodgkin's lymphoma ovarian cancer Advanced Solid Tumor hepatocellular carcinoma breast cancer cervix carcinoma lung squamous cell carcinoma lung non-small cell carcinoma lung adenocarcinoma pseudomyxoma peritonei
Therapies	SGN1
Age Groups:	senior \| adult
Covered Countries